Loading...
75N98026Q00800
Response Deadline
Jul 25, 2026, 1:00 PM(EDT)10 days
Eligibility
Contract Type
Solicitation
Requirements:
2.0 BACKGROUND
Our lab studies the role of inflammation/innate resistance and commensal microbiota in carcinogenesis, cancer progression and therapy of cancer.
The following product features/characteristics are required for this requirement:
Protein Coverage - Measures ~5,400+ human proteins simultaneously in a single workflow.
Technology - Uses Proximity Extension Assay (PEA) with dual antibody recognition coupled to DNA barcoding and next-generation sequencing (NGS) readout.
Sample input – requires only 2 ul of plasma, serum, and other sample types
Specificity - Reported 99.5% specificity with negligible cross-reactivity due to dual-recognition antibody design.
Dynamic Range - Approximately 10 orders of magnitude (fg/mL to mg/mL), enabling detection of both low- and high-abundance proteins.
Key strengths
John Burton
DEPARTMENT OF HEALTH AND HUMAN SERVICES
NATIONAL INSTITUTES OF HEALTH
NATIONAL INSTITUTES OF HEALTH OLAO
NATIONAL INSTITUTES OF HEALTH OLAO
6011 EXECUTIVE BLVD., SUITE 503L
BETHESDA, MD, 20892
NAICS
Testing Laboratories and Services
PSC
REFERENCE LABORATORY TESTING
Set-Aside
No Set aside used